Keeping Track: US FDA Greenlights Two More Novel Drugs, But Smacks Down Golodirsen

 
• By Michael Cipriano, Bridget Silverman, and Brenda Sandburg
Keeping Track Feature image
The FDA approved Xenleta and Ga-68-DOTATOC but issued a complete response letter for golodirsen.

More from Approvals

More from Product Reviews